DOLPAC 10 tablete za srednje velike pse
Country: Slovenia
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
04-03-2012
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
oxantel embonate 200.28 mg, praziquantel 50 mg, pyrantel embonate 49.94 mg
Available from:
Vetoquinol
ATC code:
QP52AA51
Pharmaceutical form:
Tablet
Therapeutic group:
praziquantel, combinations
Therapeutic area:
Dogs
Authorization date:
2011-05-19
Summary of Product characteristics
VETOQUINOL/DOLPAC MEDIUM DOGS/ EUROPEAN RENEWAL
JUNE 2011
1/5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Austria
Belgium
Cyprus
Malta
Czech Republic
Netherlands
Greece
Portugal
Slovakia
Hungary
Slovenia
Germany
Finland
Dolpac medium dogs tablets
France Luxembourg
Dolpac 10 comprimé
UK-Ireland-Italy
Dolpac Tablets for Medium Dogs
Spain Poland
Dolpac medium dogs tablets for 5-20
kg
Denmark
Sweden
Dolpac vet medium dogs tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains :
Active substances
Oxantel
200.28 mg (equivalent to 559 mg of oxantel embonate)
Pyrantel
49.94 mg (equivalent to 144 mg of pyrantel embonate)
Praziquantel
50.00 mg
Excipient to one 950 mg divisible tablet
Excipients
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Tablet
Pale yellow to yellow oblong tablet with breaking line.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For curative treatment of dogs harbouring mixed parasitic infestations with the following adult stages
of nematode and cestode species:
Nematodes:
_ _
_ _
_Toxocara canis _
_ _
_ _
_Toxascaris leonina_
_ _
_ _
_Ancylostoma caninum_
_ _
_ _
_Uncinaria stenocephala_
VETOQUINOL/DOLPAC MEDIUM DOGS/ EUROPEAN RENEWAL
JUNE 2011
2/5
_ _
_ _
_Trichuris vulpis_
Cestodes:
_ _
_ _
_Dipylidium caninum _
_ _
_ _
_Taenia _spp
_ _
_ _
_ _
_Echinococcus multilocularis_
_ _
_ _
_Echinococcus granulosus _
4.3
CONTRAINDICATIONS
See section 4.8
4.4
SPECIAL
Read the complete document
